Winrevair (sotatercept)

pCPA File Number: 22911

Negotiation Status:

Under consideration for negotiation

Indication(s):

Pulmonary Arterial Hypertension (WHO group 1)

Sponsor/Manufacturer:

Merck Canada Inc.

CDA-AMC Project Number:

SR0828-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable